The Foundation for Technological Innovation is granting two new loans to Twiice and Nexco Analytics. Twiice has been awarded a Tech Growth loan of CHF 400,000 for the development of its unique exoskeleton, and Nexco Analytic has been awarded a Tech Seed loan of CHF 100,000 for its software solution (Saas) to accelerate research processes in genomic analysis..

技术创新基金会正在向Twiice和Nexco Analytics发放两笔新贷款。Twiice已获得40万瑞士法郎的技术增长贷款，用于开发其独特的外骨骼，Nexco Analytical已获得10万瑞士法郎的技术种子贷款，用于其软件解决方案（Saas），以加速基因组分析的研究过程。。

According to the WHO, 65 million people worldwide require a wheelchair to get around. Depending on the type of injury, using an exoskeleton to restore patients' mobility is a possibility, although one that is still largely untapped. Since 2016, Twiice has been developing an exoskeleton that has established itself over the years as the most integrated, slimmest and lightest of all the exoskeletons currently available on the market.

。根据损伤的类型，使用外骨骼恢复患者的活动能力是一种可能性，尽管这种可能性在很大程度上尚未开发。自2016年以来，Twiice一直在开发一种外骨骼，多年来已成为目前市场上所有外骨骼中最完整，最薄，最轻的外骨骼。

This feat is made possible by a unique production technique based on digital manufacturing, which enables high-performance structures (light and compact) to be produced in small batches at an affordable price. Twiice exoskeletons are designed for mobility assistance and rehabilitation for people suffering from spinal cord injuries, strokes, multiple sclerosis and locomotor deficiencies.

这一壮举是通过基于数字制造的独特生产技术实现的，该技术能够以可承受的价格小批量生产高性能结构（轻而紧凑）。Twiice外骨骼旨在为患有脊髓损伤、中风、多发性硬化症和运动缺陷的人提供活动辅助和康复。

And because each patient requires individualised assistance, adapted to their stage of rehabilitation or level of injury, the Twiice exoskeleton incorporates intelligent assistance that naturally ‘guides’ the patient in a perfectly measured way according to their needs The first generation of exoskeletons currently under development will be designed for use both in clinics as a therapeutic tool (which is the current practice) and in patients' homes under the supervision of a coach, which would be completely new. The CHF 400,000 Tech Growth loan provided by FIT will enable Twiice to continue developing its 2nd and 3rd generation exoskeletons.  These future generations will be adapted to the activities of daily life and will provide greater independence for people with reduced mobility. Nexco Analytics streamlines genomic analysis research processes with digital technologyThe global life sciences industry is undergoing a rapid digital transformation.

由于每位患者都需要个性化的帮助，以适应他们的康复阶段或受伤程度，Twiice外骨骼结合了智能帮助，可以根据患者的需求以完美的方式自然地“引导”患者。目前正在开发的第一代外骨骼将被设计用于诊所作为治疗工具（目前的做法）和在教练的监督下在患者家中使用，这将是全新的。。这些后代将适应日常生活活动，并为行动不便的人提供更大的独立性。Nexco Analytics利用数字技术简化了基因组分析研究过程全球生命科学行业正在经历快速的数字转型。

Genomic anal.

基因组肛门。

0Comments

0注意事项

Back to all news

返回所有新闻

Please login

请登录

or sign up

或注册

to comment.

发表评论。

Commenting guidelines

评论指南

Send

发送